2020
DOI: 10.1016/j.cell.2020.11.005
|View full text |Cite
|
Sign up to set email alerts
|

Guide RNA Categorization Enables Target Site Choice in Tn7-CRISPR-Cas Transposons

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
75
2

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 85 publications
(80 citation statements)
references
References 49 publications
3
75
2
Order By: Relevance
“…MUCICAT is simple to operate and machine friendly, showing great potential to be applied by laboratory automation systems to revolutionize cell programming. As more and more types of CRISPR-Cas transposase systems are discovered, 34 MUCI-CAT can introduce multiple orthogonal systems to produce two-dimensional, three-dimensional, or even multidimensional diversity changes in organisms, such as (1) system A produces m kinds of gene disruption diversity and system B produces n copies of gene integration diversity; (2) system A generates diversity of m copies for pathway 1 and system B generates diversity of n copies for pathway 2, and so on; and (3) combining ( 1) and (2) to create more possibilities. Furthermore, this technology has the potential to be applied to bacteria other than E. coli.…”
Section: Discussionmentioning
confidence: 99%
“…MUCICAT is simple to operate and machine friendly, showing great potential to be applied by laboratory automation systems to revolutionize cell programming. As more and more types of CRISPR-Cas transposase systems are discovered, 34 MUCI-CAT can introduce multiple orthogonal systems to produce two-dimensional, three-dimensional, or even multidimensional diversity changes in organisms, such as (1) system A produces m kinds of gene disruption diversity and system B produces n copies of gene integration diversity; (2) system A generates diversity of m copies for pathway 1 and system B generates diversity of n copies for pathway 2, and so on; and (3) combining ( 1) and (2) to create more possibilities. Furthermore, this technology has the potential to be applied to bacteria other than E. coli.…”
Section: Discussionmentioning
confidence: 99%
“…For VchCAST, pDonorVerA(Vch), pTns(Vch) and pQCascade(Vch)-crRNA4 with the tetracycline (Tet) promoter were used. For AsaCAST, pMTP170 ( 7 )(Addgene #164263) was reconstructed to target the lacZ gene (spacer #6 as reported) and pDonorAsa derived from pMTP112 ( 7 ) (Addgene #164260) was reconstructed as well. They were used together with pMTP130 ( 7 ) (Addgene #162461) and pMTP140 ( 7 ) (Addgene #164262).…”
Section: Methodsmentioning
confidence: 99%
“…reported that VchCAST and type V-K CAST from Scytonema hofmannii PCC 7110 (ShoCAST) were orthogonal in that they recognize different transposon ends ( 12 ), but type V-K CASTs tend to cointegrate its donor plasmid ( 13–16 ) due to lack of protein TnsA activity, and have a relatively low integration efficiency on multiple targets ( 2 ). Type I-F3 CAST from Aeromonas salmonicida S44 (AsaCAST) exhibits RNA-guided DNA transposition activity when introduced to E. coli , but the integration efficiency of AsaCAST seems much lower than VchCAST ( 7 ). Highly active CASTs capable of MUCICAT need to be identified for the implementation of a parallel and multiplexed genome editing system with VchCAST.…”
Section: Introductionmentioning
confidence: 99%
“…Prokaryotes have evolved genome defense mechanisms to restrict parasitic transposition, including adaptive immunity provided by CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR associated) systems that rely on Cas proteins and CRISPR RNA (crRNA) guides to target invasive genetic elements for nucleolytic degradation 1,10 . In contrast to the defensive role of canonical CRISPR-Cas systems, several nucleasedeficient type I-F, I-B and V-K systems have been instead co-opted by a distinct group of Tn7-like transposons to direct RNA-guided transposon DNA insertion into specific target sites [2][3][4][5][6][7] . In these systems, DNA targeting relies on transposon-encoded Cas-RNPs, involving a Cas3-less multisubunit effector complex (termed Cascade) in type I systems 3 or a single catalytically inactive Cas12k protein in type V-K systems 7 .…”
Section: Introductionmentioning
confidence: 99%
“…
Although the canonical function of CRISPR-Cas systems is to provide adaptive immunity against mobile genetic elements 1 , type I-F, I-B and V-K systems have been adopted by Tn7-like transposons to direct RNA-guided transposon insertion [2][3][4][5][6][7] . Type V-K CRISPR-associated transposons rely on the activities of the pseudonuclease Cas12k, the transposase TnsB, the AAA+ ATPase TnsC and the zinc-finger protein TniQ 7 .
…”
mentioning
confidence: 99%